WallStreetZenWallStreetZen

NASDAQ: RNA
Avidity Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RNA past revenue growth

How has RNA's revenue growth performed historically?
Company
3.64%
Industry
145.73%
Market
17.2%
RNA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RNA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RNA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RNA earnings and revenue history

Current Revenue
$9.6M
Current Earnings
-$212.2M
Current Profit Margin
-2,219.9%

RNA Return on Equity

Current Company
-39.7%
Current Industry
-63.5%
Current Market
188%
RNA's Return on Equity (-39.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RNA announces earnings.

RNA Return on Assets

Current Company
-35%
Current Industry
2.9%
RNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RNA Return on Capital Employed

Current Company
-38.74%
Current Industry
19.5%
RNA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RNA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RNA$9.56M-$207.14M-$212.22M+90.71%N/A
MRVI$288.95M$731.76M-$119.03M+18.47%N/A
GLPG$260.57M$240.55M$230.11M-5.51%+5.12%
NAMS$15.32M-$192.24M-$192.32M-85.67%N/A
NTLA$36.28M-$472.22M-$481.19M+3.57%N/A
View Top Biotech Stocks

RNA earnings dates

Next earnings date
May 7, 2024

Avidity Biosciences Earnings & Revenue FAQ

What were RNA's earnings last quarter?

On Invalid Date, Avidity Biosciences (NASDAQ: RNA) reported Q4 2023 earnings per share (EPS) of -$0.80, up 10.11% year over year. Total Avidity Biosciences earnings for the quarter were -$60.44 million. In the same quarter last year, Avidity Biosciences's earnings per share (EPS) was -$0.89.

If you're new to stock investing, here's how to buy Avidity Biosciences stock.

What was RNA's earnings growth in the past year?

As of Q2 2024, Avidity Biosciences's earnings has grown year over year. Avidity Biosciences's earnings in the past year totalled -$212.22 million.

What is RNA's earnings date?

Avidity Biosciences's earnings date is Invalid Date. Add RNA to your watchlist to be reminded of RNA's next earnings announcement.

What was RNA's revenue last quarter?

On Invalid Date, Avidity Biosciences (NASDAQ: RNA) reported Q4 2023 revenue of $2.19 million up 20.8% year over year. In the same quarter last year, Avidity Biosciences's revenue was $2.77 million.

What was RNA's revenue growth in the past year?

As of Q2 2024, Avidity Biosciences's revenue has grown 3.64% year over year. This is 142.09 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Avidity Biosciences's revenue in the past year totalled $9.56 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.